Skip to content

Aurinia Pharmaceuticals AUPH Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin88.5%+0.5pp88%-4.0pp91.9%-3.8pp95.8%-1.8pp
Operating margin37.1%+39.1pp-2%+50.2pp-52.2%+30.9pp-83.2%+313pp
Net margin101.5%+99.0pp2.4%+46.9pp-44.5%+36.3pp-80.7%+316pp
Returns
Return on equity59.9%+58.4pp1.5%+21.4pp-19.9%+4.5pp-24.5%+16.4pp
Return on invested capital21.4%+22.5pp-1.1%+23.0pp-24.1%+14.6pp-38.8%+51.7pp
Efficiency
Asset turnover0.4×0.0×0.4×+0.1×0.3×+0.1×0.3×+0.2×
Liquidity
Current ratio5.2×+0.7×4.6×-0.9×5.5×-4.1×9.6×-3.0×
Leverage
Debt-to-equity0.2×-0.1×0.2×0.0×0.3×+0.3×0.0×
Net debt / EBITDA0.1×-0.6×0.7×
Per Share
Book value per share$4.19+62.3%$2.58-2.1%$2.64-7.6%$2.86-22.9%
Valuation
Market capitalization$2.1B+63.6%$1.29B0.0%$1.29B+108%$617.84M-81.1%
Price / earnings7.3×-216×223.5×
Price / sales7.4×+2.0×5.5×-1.9×7.3×+2.7×4.6×-67.1×
Price / book3.6×+0.2×3.4×0.0×3.4×+1.9×1.5×-5.3×
EV / EBITDA17×-70.8×87.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?
Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.
Where do Aurinia Pharmaceuticals's ratios come from?
Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.